+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Crotamiton Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Crotamiton Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Crotamiton Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6082682
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Crotamiton Market grew from USD 135.35 million in 2024 to USD 141.64 million in 2025. It is expected to continue growing at a CAGR of 4.51%, reaching USD 176.43 million by 2030.

Crotamiton has emerged as a cornerstone in the management of pruritic and parasitic skin conditions, commanding attention from clinicians, formulators, and industry stakeholders alike. Originally developed for its antipruritic and scabicidal properties, this versatile compound has expanded its therapeutic reach through innovative delivery systems and targeted applications. As global populations contend with rising incidences of dermatological disorders, the demand for effective, safe, and patient-friendly treatments has intensified. The compound’s dual action in suppressing itch and addressing contagion has positioned it at the intersection of allergy relief, general dermatology, insect bite management, and scabies therapy. Amid evolving regulatory frameworks, shifting patient expectations, and technological advances in formulation science, market participants are rethinking their approaches to research, development, and commercialization. This introduction establishes the context for understanding emerging trends, regulatory impacts, segmentation insights, regional dynamics, competitive landscapes, and strategic recommendations. Readers are invited to explore how these factors collectively shape the present and future trajectory of the crotamiton market, guiding informed decision-making among experts and executive leaders.

Transformative Shifts Reshaping the Crotamiton Landscape

Recent years have witnessed transformative shifts reshaping the crotamiton landscape. Advancements in nanocarrier and microemulsion technologies have enhanced skin penetration and sustained release, enabling more consistent therapeutic performance. Concurrently, precision dermatology initiatives are leveraging genomic and microbiome profiling to tailor topical treatments, prompting formulators to explore personalized crotamiton regimens. Digital health platforms now facilitate remote monitoring of patient response, allowing for real-time adjustments in application frequency and dosage. Regulatory bodies have intensified scrutiny of excipient safety and environmental impact, driving innovation in biodegradable and cruelty-free formulations. Market entrants are forming strategic alliances with digital therapeutics firms to integrate adherence-boosting features into packaging and dispensers. Moreover, repurposing efforts are examining crotamiton’s anti-inflammatory potential beyond pruritus, with exploratory studies in inflammatory dermatoses. These converging trends underline a shift from one-size-fits-all products to agile, data-driven solutions that prioritize efficacy, safety, and patient experience.

Cumulative Impact of 2025 United States Tariffs on Crotamiton

The implementation of new United States tariffs in 2025 has introduced a complex layer of supply chain and cost considerations for crotamiton manufacturers and distributors. Imported active pharmaceutical ingredients and packaging components are now subject to increased duties, elevating production costs and prompting a reevaluation of sourcing strategies. Companies reliant on international suppliers have accelerated efforts to onshore key inputs or negotiate long-term supply agreements to mitigate volatility. The tariff framework has also affected contract manufacturing organizations, which are recalibrating capacity allocations to balance domestic and export-oriented production. In response, several market participants have initiated cost-optimization programs, including lean manufacturing, strategic inventory buffering, and dynamic pricing models, to preserve margin integrity. While some players are absorbing incremental costs to maintain competitive pricing, others are seeking localized partnerships to sidestep tariff burdens. This evolving tariff environment underscores the need for adaptive procurement, robust risk management, and transparent stakeholder communication to ensure uninterrupted supply and sustained market access.

Key Segmentation Insights Across Applications, Forms, and End-Users

Market segmentation reveals critical insights across multiple dimensions. Application-wise, pruritic indications such as allergy relief leverage itch suppression and symptomatic alleviation, whereas dermatological uses focus on eczema management and psoriasis control; insect bite treatments prioritize pain relief and swelling reduction, and scabies regimens emphasize contagion containment alongside symptom suppression. Form preferences highlight consumer and clinician demand for medicated cream versus regular cream, cooling gel versus standard gel, and specialized lotions tailored to dry or oily skin types. End-user analysis underscores differentiated purchasing behaviors in dermatology clinics and private facilities, home care scenarios driven by over-the-counter accessibility and self-prescription, and hospital settings encompassing both inpatient and outpatient care pathways. Distribution channels reflect the strategic balance between volume-oriented bulk orders and direct procurement by hospital pharmacies, the rapid growth of e-commerce platforms and official manufacturer websites in online pharmacies, and the enduring role of chain retailers alongside independent pharmacies in traditional retail outlets. Treatment phase segmentation illuminates the transition from first-line therapy and preventive strategies during initial treatment through long-term maintenance use and periodic application to complementary care and recovery regimens post-treatment. Finally, patient demographics reveal nuanced demand patterns across adults aged 18-34, 35-50, and 51+, pediatric cohorts ranging from infants to toddlers and school-age children, and geriatric populations covering ages 60-75 and 76+, each requiring tailored formulation and communication approaches.

Regional Dynamics Influencing Crotamiton Adoption Globally

Regional dynamics play a pivotal role in defining market opportunities and challenges. In the Americas, robust private and public healthcare infrastructures in the United States and Canada drive high adoption rates of advanced topical therapies, while growing awareness initiatives in Latin America are expanding access to effective pruritic and scabies treatments. Across Europe, Middle East & Africa, stringent regulatory harmonization through EMA guidelines and emerging public-health campaigns in the Middle East are elevating quality standards, even as supply chain complexities persist in parts of Africa. In the Asia-Pacific region, large manufacturing hubs in China and India are strengthening global API supply, while escalating dermatological incidence rates and increasing healthcare spending in Southeast Asia and Australia are fueling demand for innovative formulations. Each region exhibits unique regulatory, economic, and demographic factors, underscoring the importance of tailored market entry and expansion strategies.

Key Company Strategies and Competitive Positioning

Key industry participants are leveraging a variety of strategic initiatives to secure competitive advantage. A.S. Lifesciences is expanding its formulation portfolio through R&D collaborations, while Abbott Laboratories integrates advanced safety data analytics to optimize product profiles. Adooq Bioscience LLC and Catapharma Chemicals Pvt. Ltd. are focusing on manufacturing excellence to enhance supply reliability, and Connote Healthcare is strengthening its global distribution network. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd. and Incepta Pharmaceuticals Ltd. are pursuing strategic licensing agreements to accelerate market entry. Merck KGaA emphasizes sustainable sourcing and biodegradable excipient development, whereas Senova Technology Co., Ltd. and SimSon Pharma Limited invest in patient-centric packaging innovations and digital adherence solutions. Taj Pharmaceuticals Limited enhances cost competitiveness through process intensification, while Zuche Pharmaceutical targets niche markets with specialized scabies treatment regimens. Together, these initiatives illustrate a competitive landscape defined by technological differentiation, supply chain resilience, and collaborative partnerships.

Actionable Recommendations for Industry Leaders

Industry leaders should adopt a multi-pronged approach to capitalize on market trends and mitigate emerging risks. First, invest in advanced formulation technologies and digital health integrations to deliver personalized, high-performance products that enhance patient adherence and outcomes. Second, diversify supply chains by establishing regional manufacturing hubs and securing long-term supplier agreements to buffer against tariff fluctuations and logistical disruptions. Third, strengthen global regulatory intelligence capabilities to navigate evolving compliance requirements across major markets, ensuring rapid approvals and market accessibility. Fourth, forge strategic partnerships with digital therapeutics firms, academic research centers, and specialty distributors to accelerate innovation and expand reach. Finally, implement data-driven commercial models that leverage real-world evidence and competitive analytics to inform pricing, positioning, and promotional strategies, driving sustainable growth and stakeholder value.

Conclusion: Positioning for Sustainable Growth

As the crotamiton market continues to evolve, stakeholders who combine technological innovation with strategic agility will emerge as industry frontrunners. By aligning formulation advancements with shifting patient expectations, proactively managing supply chain dynamics, and leveraging data-driven insights, companies can navigate tariff complexities and regional variation while safeguarding product efficacy and quality. Collaborative ecosystems spanning research institutions, digital health innovators, and specialty distributors will fuel the next wave of market expansion, ensuring that crotamiton remains a leading therapy for pruritic and parasitic skin conditions worldwide. This conclusion highlights the imperative for integrated strategies that balance operational resilience, regulatory compliance, and patient-centric innovation.

Market Segmentation & Coverage

This research report categorizes the Crotamiton Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Allergy Relief
    • Itch Suppression
    • Symptom Alleviation
  • Dermatology
    • Eczema Management
    • Psoriasis Control
  • Insect Bites
    • Pain Relief
    • Swelling Reduction
  • Scabies Treatment
    • Contagion Control
    • Symptom Suppression
  • Cream
    • Medicated Cream
    • Regular Cream
  • Gel
    • Cooling Gel
    • Regular Gel
  • Lotion
    • Dry Skin Lotion
    • Oily Skin Lotion
  • Clinics
    • Dermatology Clinics
    • Private Clinics
  • Home Care
    • Over-the-counter
    • Self-prescription
  • Hospitals
    • Inpatient Care
    • Outpatient Care
  • Hospital Pharmacies
    • Bulk Orders
    • Direct Purchase
  • Online Pharmacies
    • E-commerce Platforms
    • Manufacturer Websites
  • Retail Pharmacies
    • Chain Stores
    • Independent Pharmacies
  • Initial Treatment
    • First-line Therapy
    • Preventive Measures
  • Maintenance Therapy
    • Long-term Use
    • Periodic Application
  • Post-Treatment
    • Complimentary Care
    • Recovery Regimen
  • Adults
    • Aged 18-34
    • Aged 35-50
    • Aged 51 and Above
  • Children
    • Infants
    • School-age
    • Toddlers
  • Geriatric Population
    • Aged 60-75
    • Aged 76 and Above

This research report categorizes the Crotamiton Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Crotamiton Market to delves into recent significant developments and analyze trends in each of the following companies:

  • A.S. Lifesciences
  • Abbott Laboratories
  • Adooq Bioscience LLC
  • Catapharma Chemicals Pvt. Ltd.
  • Connote Healthcare
  • Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
  • Incepta Pharmaceuticals Ltd.
  • Merck KGaA
  • Senova Technology Co., Ltd.
  • SimSon Pharma Limited
  • Taj Pharmaceuticals Limited
  • Zuche Pharmaceutical

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Crotamiton Market, by Application
8.1. Introduction
8.2. Allergy Relief
8.2.1. Itch Suppression
8.2.2. Symptom Alleviation
8.3. Dermatology
8.3.1. Eczema Management
8.3.2. Psoriasis Control
8.4. Insect Bites
8.4.1. Pain Relief
8.4.2. Swelling Reduction
8.5. Scabies Treatment
8.5.1. Contagion Control
8.5.2. Symptom Suppression
9. Crotamiton Market, by Form
9.1. Introduction
9.2. Cream
9.2.1. Medicated Cream
9.2.2. Regular Cream
9.3. Gel
9.3.1. Cooling Gel
9.3.2. Regular Gel
9.4. Lotion
9.4.1. Dry Skin Lotion
9.4.2. Oily Skin Lotion
10. Crotamiton Market, by End-user
10.1. Introduction
10.2. Clinics
10.2.1. Dermatology Clinics
10.2.2. Private Clinics
10.3. Home Care
10.3.1. Over-the-counter
10.3.2. Self-prescription
10.4. Hospitals
10.4.1. Inpatient Care
10.4.2. Outpatient Care
11. Crotamiton Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.2.1. Bulk Orders
11.2.2. Direct Purchase
11.3. Online Pharmacies
11.3.1. E-commerce Platforms
11.3.2. Manufacturer Websites
11.4. Retail Pharmacies
11.4.1. Chain Stores
11.4.2. Independent Pharmacies
12. Crotamiton Market, by Treatment Phase
12.1. Introduction
12.2. Initial Treatment
12.2.1. First-line Therapy
12.2.2. Preventive Measures
12.3. Maintenance Therapy
12.3.1. Long-term Use
12.3.2. Periodic Application
12.4. Post-Treatment
12.4.1. Complimentary Care
12.4.2. Recovery Regimen
13. Crotamiton Market, by Patient Demographics
13.1. Introduction
13.2. Adults
13.2.1. Aged 18-34
13.2.2. Aged 35-50
13.2.3. Aged 51 and Above
13.3. Children
13.3.1. Infants
13.3.2. School-age
13.3.3. Toddlers
13.4. Geriatric Population
13.4.1. Aged 60-75
13.4.2. Aged 76 and Above
14. Americas Crotamiton Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Crotamiton Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Crotamiton Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. A.S. Lifesciences
17.3.2. Abbott Laboratories
17.3.3. Adooq Bioscience LLC
17.3.4. Catapharma Chemicals Pvt. Ltd.
17.3.5. Connote Healthcare
17.3.6. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
17.3.7. Incepta Pharmaceuticals Ltd.
17.3.8. Merck KGaA
17.3.9. Senova Technology Co., Ltd.
17.3.10. SimSon Pharma Limited
17.3.11. Taj Pharmaceuticals Limited
17.3.12. Zuche Pharmaceutical
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CROTAMITON MARKET MULTI-CURRENCY
FIGURE 2. CROTAMITON MARKET MULTI-LANGUAGE
FIGURE 3. CROTAMITON MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CROTAMITON MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CROTAMITON MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CROTAMITON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CROTAMITON MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CROTAMITON MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CROTAMITON MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CROTAMITON MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CROTAMITON MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CROTAMITON MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CROTAMITON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CROTAMITON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CROTAMITON MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CROTAMITON MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CROTAMITON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CROTAMITON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CROTAMITON MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CROTAMITON MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CROTAMITON MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CROTAMITON MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CROTAMITON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CROTAMITON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CROTAMITON MARKET SIZE, BY ITCH SUPPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CROTAMITON MARKET SIZE, BY SYMPTOM ALLEVIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CROTAMITON MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CROTAMITON MARKET SIZE, BY ECZEMA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CROTAMITON MARKET SIZE, BY PSORIASIS CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CROTAMITON MARKET SIZE, BY INSECT BITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CROTAMITON MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CROTAMITON MARKET SIZE, BY SWELLING REDUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CROTAMITON MARKET SIZE, BY CONTAGION CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CROTAMITON MARKET SIZE, BY SYMPTOM SUPPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CROTAMITON MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CROTAMITON MARKET SIZE, BY MEDICATED CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CROTAMITON MARKET SIZE, BY REGULAR CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CROTAMITON MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CROTAMITON MARKET SIZE, BY COOLING GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CROTAMITON MARKET SIZE, BY REGULAR GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CROTAMITON MARKET SIZE, BY LOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CROTAMITON MARKET SIZE, BY DRY SKIN LOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CROTAMITON MARKET SIZE, BY OILY SKIN LOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CROTAMITON MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CROTAMITON MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CROTAMITON MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CROTAMITON MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CROTAMITON MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CROTAMITON MARKET SIZE, BY SELF-PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CROTAMITON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CROTAMITON MARKET SIZE, BY INPATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CROTAMITON MARKET SIZE, BY OUTPATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CROTAMITON MARKET SIZE, BY BULK ORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CROTAMITON MARKET SIZE, BY DIRECT PURCHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CROTAMITON MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CROTAMITON MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CROTAMITON MARKET SIZE, BY CHAIN STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CROTAMITON MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CROTAMITON MARKET SIZE, BY FIRST-LINE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CROTAMITON MARKET SIZE, BY PREVENTIVE MEASURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CROTAMITON MARKET SIZE, BY LONG-TERM USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CROTAMITON MARKET SIZE, BY PERIODIC APPLICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CROTAMITON MARKET SIZE, BY POST-TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CROTAMITON MARKET SIZE, BY COMPLIMENTARY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL CROTAMITON MARKET SIZE, BY RECOVERY REGIMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL CROTAMITON MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL CROTAMITON MARKET SIZE, BY AGED 18-34, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL CROTAMITON MARKET SIZE, BY AGED 35-50, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL CROTAMITON MARKET SIZE, BY AGED 51 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL CROTAMITON MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL CROTAMITON MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL CROTAMITON MARKET SIZE, BY SCHOOL-AGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL CROTAMITON MARKET SIZE, BY TODDLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL CROTAMITON MARKET SIZE, BY AGED 60-75, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL CROTAMITON MARKET SIZE, BY AGED 76 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS CROTAMITON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 166. CANADA CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. CANADA CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 168. CANADA CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 169. CANADA CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 170. CANADA CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 171. CANADA CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 172. CANADA CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 173. CANADA CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 174. CANADA CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 175. CANADA CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. CANADA CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 177. CANADA CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 178. CANADA CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 179. CANADA CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. CANADA CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 181. CANADA CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 182. CANADA CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 183. CANADA CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 184. CANADA CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 185. CANADA CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 186. CANADA CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 187. CANADA CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 188. CANADA CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 189. CANADA CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 190. CANADA CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 191. MEXICO CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. MEXICO CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 193. MEXICO CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 194. MEXICO CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 195. MEXICO CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 196. MEXICO CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 197. MEXICO CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 198. MEXICO CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 199. MEXICO CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 200. MEXICO CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. MEXICO CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 202. MEXICO CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 203. MEXICO CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 204. MEXICO CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. MEXICO CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 206. MEXICO CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 207. MEXICO CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 208. MEXICO CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 209. MEXICO CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 210. MEXICO CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 211. MEXICO CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 212. MEXICO CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 213. MEXICO CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 214. MEXICO CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 215. MEXICO CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 228. UNITED STATES CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 239. UNITED STATES CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 240. UNITED STATES CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 241. UNITED STATES CROTAMITON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 275. AUSTRALIA CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 276. AUSTRALIA CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 277. AUSTRALIA CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. AUSTRALIA CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 279. AUSTRALIA CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 280. AUSTRALIA CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 281. AUSTRALIA CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. AUSTRALIA CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 283. AUSTRALIA CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 284. AUSTRALIA CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 285. AUSTRALIA CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 286. AUSTRALIA CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 287. AUSTRALIA CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 288. AUSTRALIA CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 289. AUSTRALIA CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 290. AUSTRALIA CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 291. AUSTRALIA CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 292. AUSTRALIA CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 293. CHINA CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. CHINA CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 295. CHINA CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 296. CHINA CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 297. CHINA CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 298. CHINA CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 299. CHINA CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 300. CHINA CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 301. CHINA CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 302. CHINA CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 303. CHINA CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 304. CHINA CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 305. CHINA CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 306. CHINA CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. CHINA CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 308. CHINA CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 309. CHINA CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 310. CHINA CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 311. CHINA CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 312. CHINA CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 313. CHINA CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 314. CHINA CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 315. CHINA CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 316. CHINA CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 317. CHINA CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 318. INDIA CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. INDIA CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 320. INDIA CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 321. INDIA CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 322. INDIA CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 323. INDIA CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 324. INDIA CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 325. INDIA CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 326. INDIA CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 327. INDIA CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 328. INDIA CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 329. INDIA CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 330. INDIA CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 331. INDIA CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 332. INDIA CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 333. INDIA CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 334. INDIA CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 335. INDIA CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 336. INDIA CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 337. INDIA CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 338. INDIA CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 339. INDIA CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 340. INDIA CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 341. INDIA CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 342. INDIA CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 343. INDONESIA CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 344. INDONESIA CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 345. INDONESIA CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 346. INDONESIA CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 347. INDONESIA CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 348. INDONESIA CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 349. INDONESIA CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 350. INDONESIA CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 351. INDONESIA CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 352. INDONESIA CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 353. INDONESIA CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 354. INDONESIA CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 355. INDONESIA CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 356. INDONESIA CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 357. INDONESIA CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 358. INDONESIA CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 359. INDONESIA CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 360. INDONESIA CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 361. INDONESIA CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 362. INDONESIA CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 363. INDONESIA CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 364. INDONESIA CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 365. INDONESIA CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 366. INDONESIA CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 367. INDONESIA CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 368. JAPAN CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 369. JAPAN CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 370. JAPAN CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 371. JAPAN CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 372. JAPAN CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 373. JAPAN CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 374. JAPAN CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 375. JAPAN CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 376. JAPAN CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 377. JAPAN CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 378. JAPAN CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 379. JAPAN CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 380. JAPAN CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 381. JAPAN CROTAMITON MARKET SIZE, BY DISTRI

Companies Mentioned

  • A.S. Lifesciences
  • Abbott Laboratories
  • Adooq Bioscience LLC
  • Catapharma Chemicals Pvt. Ltd.
  • Connote Healthcare
  • Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
  • Incepta Pharmaceuticals Ltd.
  • Merck KGaA
  • Senova Technology Co., Ltd.
  • SimSon Pharma Limited
  • Taj Pharmaceuticals Limited
  • Zuche Pharmaceutical

Methodology

Loading
LOADING...

Related Topics

Related Reports

Crotamiton Market by Formulation Type, Concentration, Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Crotamiton Market by Formulation Type, Concentration, Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Crotamiton (CAS 483-63-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Crotamiton (CAS 483-63-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Tinea Pedis Treatment Market by Type, Indication Type, Route Of Administration, Sales Channel - Global Forecast 2025-2030 - Product Image

Tinea Pedis Treatment Market by Type, Indication Type, Route Of Administration, Sales Channel - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Sepsis Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Glycopeptide, Aminoglycosides), By Route Of Administration (Parenteral, Oral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Sepsis Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Glycopeptide, Aminoglycosides), By Route Of Administration (Parenteral, Oral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 153 Pages
  • Global
From
Infectious Disease Therapeutics Market Size, Share & Trends Analysis Report By Infection (Bacterial, Viral), By Drug Class (Antibacterial, Antiviral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Infectious Disease Therapeutics Market Size, Share & Trends Analysis Report By Infection (Bacterial, Viral), By Drug Class (Antibacterial, Antiviral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From

About the Crotamiton Market

Crotamiton is a topical antipruritic and scabicidal drug used to treat skin conditions caused by infectious diseases. It is used to treat scabies, a contagious skin infestation caused by the mite Sarcoptes scabiei, as well as other skin conditions such as pruritus, dermatitis, and eczema. It is available in both cream and lotion forms and is typically applied to the affected area two to three times a day. Crotamiton is a safe and effective treatment for scabies and other skin conditions caused by infectious diseases. It is generally well tolerated and has few side effects. It is also relatively inexpensive, making it an attractive option for those who cannot afford more expensive treatments. Some companies that produce and market crotamiton include GlaxoSmithKline, Merck, and Bayer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.